By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Elan Corporation PLC 

Treasury Building
Lower Grand Canal Street
Dublin    2  Ireland
Phone: 353-1-709-4000 Fax: 353-1-709-4700



Drug Delivery


Athersys  A joint venture to develop and commercialize a specific therapeutic protein. Athersys is contributing the protein production capabilities of its RAGE technology and Elan is contributing a proprietary drug delivery technology.

Norseman, Inc.  Strategic Partnership - Web based Digital Document Delivery software

Neurome, Inc.  The research partnership with Elan has an initial term of 3 years and may generate up to $4 million in service revenue for Neurome, together with shared ownership of the diagnostic and therapeutic applications of the genes, circuits and mechanisms identified in the research. The partnership will utilize Neurome's technologies to analyze a mouse model of Alzheimer's Disease with the goal of identifying and exploiting molecules and pathways relevant to diagnosis and treatment of the disease. The partnership will analyze Elan's proprietary mouse model of amyloid deposition in an attempt to answer a variety of scientific questions regarding amyloid deposition.

Biogen  (crohn's & MS)

Digital Gene Technologies  Alzheimer's Disease, Parkinson's Disease, novel mechanisms for drug delivery

RxKinetix, Inc.  Joint venture for the treatment of oral mucositis

NewBiotics, Inc. 


Biogen Idec, Inc. (North Carolina)  (crohn's & MS)

Company News
Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen (BIIB)-Elan (ELN) Exec 8/14/2017 5:38:30 AM
Controversial Elan (ELN) Boss Kelly Martin to Head Malin 8/27/2015 6:17:34 AM
Precise Biometrics AB Signs License Agreement With Elan (ELN) 8/3/2015 11:19:24 AM
Former Elan (ELN) CEO Takes Helm Of Expanded Serenus Board Of Directors 6/11/2015 11:12:51 AM
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics 3/25/2015 6:27:34 AM
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO 3/4/2015 6:51:45 AM
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million 3/3/2015 6:08:15 AM
Ex-Elan Corporation PLC (ELN) Trio Snags Their Former Employer’s Kinase Inhibitor Program 9/29/2014 7:18:51 AM
San Francisco-Based Serenus Biotherapeutics Established, Company Will Be Led By Ex-Elan Corporation PLC (ELN) Exec Menghis Bairu 6/19/2014 12:22:01 PM
Perrigo Company (PRGO) Completes Acquisition Of Elan Corporation PLC (ELN) 12/19/2013 10:10:06 AM